Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

98.12
Delayed Data
As of Sep 20
 +1.92 / +2.00%
Today’s Change
85.88
Today|||52-Week Range
172.95
-9.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues5.2M13.8M21.0M30.9M
 
 
 
 
 
Cost of Goods Sold----97.0K279.0K
 
 
 
Depreciation And Amortization643.0K1.6M802.0K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income----20.1M29.5M
 
 
 
General Expenses87.6M126.2M104.1M110.0M
 
 
 
 
 
Research And Development43.8M53.8M43.8M44.2M
 
 
 
 
 
Total Operating Expenses88.2M127.8M105.0M111.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-83.0M-114.0M-84.0M-80.5M
 
 
 
 
 
Interest Expense On Debt7.1M7.1M7.2M7.3M
 
 
 
 
 
Other Expenses1.3M1.1M1.2M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-88.8M-120.0M-89.9M-86.6M
 
 
 
 
 
Net Income-88.8M-120.0M-89.9M-86.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.7M24.8M24.9M25.0M
 
 
 
 
 
Shares To Calculate EPS Diluted24.7M24.8M24.9M25.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.59-$4.84-$3.61-$3.46
 
 
 
 
 
EPS Diluted-$3.59-$4.84-$3.61-$3.46